Why Viking Therapeutics Stock Was So Healthy on Wednesday [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
Viking Therapeutics (NASDAQ: VKTX) , a biotech stock that has rocketed to prominence thanks to one of its investigational drugs, gave investors more reason to like it on Wednesday. The company's share price rose by almost 2% following an analyst's bullish new research note; that increase stood in positive contrast to the 0.2% decline of the S&P 500 index. Weight loss drug in the spotlight The author of that note was Oppenheimer 's Jay Olson, who reiterated his outperform (i.e., buy) recommendation on Viking stock, and his $138-per-share price target. The biotech has appeared on the radars of numerous analysts and many investors because of its VK2735, an investigational drug that targets obesity. This is the hottest segment of the pharmaceutical market, with GLP-1 medications flying off pharmacy shelves in this country. VK2735 has demonstrated good efficacy in clinical testing so far, raising hopes that it could be a blockbuster in a market that still has room for competition.
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics, Inc. (VKTX) Falls More Steeply Than Broader Market: What Investors Need to Know [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (VKTX) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics, Inc. (NASDAQ: VKTX) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $138.00 price target on the stock.MarketBeat
- Viking Therapeutics, Inc. (NASDAQ: VKTX) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- .50% Cut May Cause A Melt-Up, The Fed Must Curtail Expectations [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 7/24/24 - Beat
VKTX
Sec Filings
- 9/20/24 - Form 4
- 9/20/24 - Form 4
- 9/20/24 - Form 144
- VKTX's page on the SEC website